See More

€500,000 Funding for Medical Research: Galeon Shakes DeSci with its DAO’s First Use Case

2 mins
Updated by Maria Petrova
Join our Trading Community on Telegram
Editorial Note: The following content does not reflect the views or opinions of BeInCrypto. It is provided for informational purposes only and should not be interpreted as financial advice. Please conduct your own research before making any investment decisions.

Galeon, an AI-powered health community project, announces funding of 500,000 euros with no counterpart for the repurposing of drugs. Today, Galeon launches a worldwide call for applications from doctors and scientists who have observed possible drug repurposing.

Drug repurposing is the use of known drugs for diseases they were not intended to cure initially. This move rigorously follows DeSci’s (Decentralized Science) core values of borderless Internet-powered science.

Once the projects are selected by a scientific committee of experts, Galeon will finance the study to be conducted to scientifically validate this repurposing. A first in the startup landscape. But most of all, a first use case for Galeon’s DAO.

Repurposing Drugs for Maximum DeSci Impact

Repurposing existing drugs for new diseases holds immense promise for faster and more affordable treatments. However, traditional funding models often fall short due to centralized control and misaligned priorities. Galeon’s DeSci approach disrupts this paradigm.

Galeon Pioneers: A Community of Scientific Innovators

Galeon’s vision is to decentralize access to secure medical data across hospitals, fostering a global community of passionate researchers and innovators – the Galeon Pioneers. This empowers a collaborative environment where scientific innovation thrives.

Community-Driven Funding: DAO for Promising Research

Galeon is seeking promising drug repurposing candidates. Up to €500,000 will be allocated to fund essential studies, with projects selected by an independent scientific committee. Uniquely, Galeon’s DAO, co-governed by patients (50%) and $GALEON token holders (50%), will also participate in the selection process. This DAO ensures funding is directed towards research with the greatest potential to benefit patients.

Open Call to Doctors and Scientists

Doctors and scientists can submit drug repurposing proposals through an online form: here

Galeon’s Unwavering Commitment

Galeon’s funding comes with no strings attached, 100% from its own funds. Galeon’s objective is to propel medical research forward and unlock innovative treatments for all.

Support Galeon to revolutionize medical research with the power of DeSci.

For more information, visit our website or contact us on our social networks.

About

Galeon is a revolutionary AI-powered health community that empowers patients, researchers, and healthcare professionals to collaborate and drive innovation in medicine. By leveraging the power of Medical AI and blockchain, Galeon is accelerating the discovery of life-saving treatments and making healthcare more accessible and affordable for everyone.

More info here

Top crypto platforms | April 2024

Disclaimer

This article contains a press release provided by an external source and may not necessarily reflect the views or opinions of BeInCrypto. In compliance with the Trust Project guidelines, BeInCrypto remains committed to transparent and unbiased reporting. Readers are advised to verify information independently and consult with a professional before making decisions based on this press release content. Please note that our Terms and ConditionsPrivacy Policy, and Disclaimers have been updated.

images-e1706008039676.jpeg
Advertorial
Advertorial is the universal author name for all the sponsored content provided by BeInCrypto partners. Therefore, these articles, created by third parties for promotional purposes, may not align with BeInCrypto views or opinion. Although we make efforts to verify the credibility of featured projects, these pieces are intended for advertising and should not be regarded as financial advice. Readers are encouraged to conduct independent research (DYOR) and exercise caution. Decisions based on...
READ FULL BIO
Sponsored
Sponsored